Navigation Links
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
Date:11/7/2011

hould be closely monitored for the development of signs and symptoms of infection during and after treatment with CIMZIA, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which CIMZIA is a member.  CIMZIA is not indicated for use in pediatric patients.

Patients treated with CIMZIA are at an increased risk for developing serious infections involving various organ systems and sites that may lead to hospitalization or death.  Opportunistic infections due to bacterial, mycobacterial, invasive fungal, viral, parasitic, or other opportunistic pathogens including aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis and tuberculosis have been reported with TNF blockers.  Patients have frequently presented with disseminated rather than localized disease.

Treatment with CIMZIA should not be initiated in patients with an active infection, including clinically important localized infections. CIMZIA should be discontinued if a patient develops a serious infection or sepsis.  Patients greater than 65 years of age, patients with co-morbid conditions, and/or patients taking concomitant immunosuppressants (e.g. corticosteroids or methotrexate) may be at a greater risk of infection.  Patients who develop a new infection during treatment with CIMZIA should be closely monitored, undergo a prompt and complete diagnostic workup appropriate for immunocompromised patients, and appropriate antimicrobial therapy should be initiated.  Appropriate empiric antifungal therapy should also be considered while a diagnostic workup is performed for patients who develop a serious systemic illness and reside or travel in regions where my
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
4. Reportlinker Adds Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
8. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
9. Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital
10. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
11. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 Immune Pharmaceuticals ... today that it intends to expand its planned bullous ... monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an orphan ... patients in the US and Europe ... start enrolling patients in a Phase II clinical trial ...
(Date:3/31/2015)... , March 31, 2015  CVS Health (NYSE: ... into new clinical affiliations with Rush University Medical ... and Tucson Medical Center in Tucson, ... Arizona Connected Care. These affiliations will help enhance ... patients. Through these clinical affiliations, CVS Health will ...
(Date:3/31/2015)... 27, 2015 Research and Markets ... the "European Laboratory Information System (LIS) Market ... (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory ... to their offering. The European laboratory ... a CAGR of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
... Md., Nov. 25 Remedium Technologies Inc., a company developing ... prize and $10,000 in the Most Promising Security Idea category ... , Selected from more than 100 entries from around the ... Summit conference held at the London School of Business. ...
... , NEW YORK, ... research report is available in its catalogue: , ... 2015 , http://www.reportlinker.com/p0158733/United-States-Dental-Devices-Market-Analysis-and-Forecasts-to-2015.html , United States ... Summary , This report is an essential ...
Cached Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13
(Date:3/31/2015)... (PRWEB) March 31, 2015 Tickets are ... show and Denver tradition since 1973. The 2015 Spring ... of Showtime on Ice. On April 24 in partnership ... event and opening night tribute to the Pat Bowlen ... A portion of the opening event proceeds will go ...
(Date:3/31/2015)... 2015 Fitbody Personal Training LLC invites participants ... night or Saturday morning workouts away from the gym and ... from FitBody Personal Training LLC. The classes are moving outdoors. ... Grashof, offers boot camp outdoors on Thursday evenings starting April ... for this next session starts on April 11th and ends ...
(Date:3/31/2015)... QMedET Solutions, LLC, is now offering ... most advanced speech recognition technology to another important ... experience the full benefits of a speech-enabled practice ... services that ensure successful integration with leading Electronic ... to provide Dragon Medical Practice Edition 2 as ...
(Date:3/31/2015)... 31, 2015 The Oliver Law Group ... in response to client requests after Zofran lawsuits were ... manufacturer, GlaxoSmithKline (GSK) failed to warn physicians and their ... the medication and “illegally and fraudently” promoted Zofran as ... receiving approval for that use from the U.S. Food ...
(Date:3/31/2015)... AL (PRWEB) March 31, 2015 The ... will be discussed during a Case Management Conference ... Southern District of New York on April 21st. According ... of a multidistrict litigation established for Mirena lawsuits filed ... ectopic pregnancies and other serious complications related to the ...
Breaking Medicine News(10 mins):Health News:FitBody Personal Training LLC Announces its Personal Training Classes are Moving Outdoors 2Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 3Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3
... shown conflicting results over whether hormone replacement therapy is ... study however examines the pros and cons of this ... HRT therapy for five years. All the women studied ... menopausal symptoms, while others did not.Results showed women free ...
... during pregnancy may increase the likelihood of eczema and ... to a recent study.// ,2,000 women were studied ... development of asthma and eczema in children. The full ... The participants were required to fill out questionnaires that ...
... who carry a gene that produces a higher level ... risk for stroke.// ,Researchers reviewed medical literature on ... previous study results were observational in nature. A standard ... by looking at data on the link between homocysteine ...
... of the New Year has brought with it a new ... failure. For these //patients the uphill struggle doesn’t stop with ... started. , Research has shown that despite all high ... still a common phenomenon. Transplant surgeon Ignazio Marino, M.D., of ...
... diabetes are risk factors for developing some types of cancer, ... million Korean patients for 10 years and tracked new cancer ... patients with diabetes and those without diabetes but with higher ... or die from cancer. The group with the highest fasting ...
... want to look for an alternative to HRT to help ... risk of experiencing a stroke .They may be especially prone ... type of stroke caused by blockage of blood to the ... patients and assessed stroke risk by type, severity and outcome. ...
Cached Medicine News:
... Tri-Flo® suction catheter design was created ... patients while still providing high suctioning ... (5/6, 8 or 10 Fr) feature ... catheter placement. Our complete catheter line ...
Suction catheter with thumb valve, two eyes, whistle tip...
Tracheal Suction Latex Rubber Catheters - Thumb Control Valve...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
Medicine Products: